1-hexadecyl-2-acetyl-glycero-3-phosphocholine and fluticasone

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with fluticasone in 1 studies

Compound Research Comparison

Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine)	Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine)	Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine)	Studies (fluticasone)	Trials (fluticasone)	Recent Studies (post-2010) (fluticasone)
9,156	187	552	3,040	1,220	941

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Acuña, AA; Barberà, JA; Chung, KF; Gabrijelcic, J; Rabinovich, R; Roca, J; Rodriguez-Roisin, R; Uribe, EM	1

Trials

1 trial(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and fluticasone

Article	Year
Fluticasone propionate attenuates platelet-activating factor-induced gas exchange defects in mild asthma. The European respiratory journal, 2002, Volume: 19, Issue:5 Topics: Administration, Inhalation; Adult; Androstadienes; Asthma; Blood Gas Analysis; Bronchodilator Agents; Cross-Over Studies; Double-Blind Method; Drug Interactions; Female; Fluticasone; Humans; Male; Platelet Activating Factor; Pulmonary Gas Exchange; Pulmonary Ventilation; Respiratory Mucosa; Time Factors; Treatment Outcome	2002

Article

Year

Fluticasone propionate attenuates platelet-activating factor-induced gas exchange defects in mild asthma.

The European respiratory journal, 2002, Volume: 19, Issue:5

Topics: Administration, Inhalation; Adult; Androstadienes; Asthma; Blood Gas Analysis; Bronchodilator Agents; Cross-Over Studies; Double-Blind Method; Drug Interactions; Female; Fluticasone; Humans; Male; Platelet Activating Factor; Pulmonary Gas Exchange; Pulmonary Ventilation; Respiratory Mucosa; Time Factors; Treatment Outcome

2002